$995.00 – $1,990.00
qPCR and dPCR Markets (Instruments, Reagents, Software/Services, Clinical and Research Markets)
Kalorama Information’s qPCR and dPCR Markets is a complete look at two imporant technologies in research and clinical practice. Th covers the qPCR and dPCR portion of the global IVD market. The report covers software, instruments and consumables, with data provided for 2014 through 2018.
CHAPTER ONE: EXECUTIVE SUMMARY
Overview
Scope and Methodology
Total Size and Growth of the Market
Issues and Trends Affecting Market
Leading Competitors
CHAPTER TWO: INTRODUCTION TO THE qPCR AND dPCR INDUSTRY
Overview
Definitions
Polymerase Chain Reaction
PCR Applications
Medical Applications
Infectious Disease Applications
Forensic Applications
Research Applications
qPCR
Digital PCR
Droplet Digital PCR
Personalized Medicine
Potential Benefits
Privacy and Public Perception
CHAPTER THREE: INDUSTRY TRENDS
The Health Industry
Population Demographics
Life Expectancy
Chronic Disease Impact
Disease and an Aging Population
Healthcare Reform in the United States
BRIC Involvement
Regulatory Structure
qPCR and Robotics
Lab-on-a Chip (LOC) Devices
Molecular Test Reimbursement
CHAPTER FOUR: REAL TIME qPCR AND dPCR PRODUCTS
Select Reagents
Select Thermocycler Instruments
Selected Reagent and Thermocycler Suppliers
Roche
Life Technologies and Thermo Fisher Scientific
Bio-Rad
Agilent Technologies
Analytik Jena
Eppendorf
Biometra (part of Analytik Jena)
Qiagen
Cephid
Sacace
Takara Bio
Fluidigm
WaferGen Biosystems
Denville Scientific
RainDance Technologies
Bibby Scientific
Abbott Molecular
Kyratec
Select Software and Services
CHAPTER FIVE: MARKET SIZE AND GROWTH
Market Considerations
Market Overview
qPCR Market by Technology
qPCR Market by Use
qPCR
dPCR
qPCR Market by Product Type
dPCR Market by Product Type
qPCR and dPCR Market by Geographical Region
Competitive Landscape
CHAPTER SIX: COMPANY PROFILES
Introduction
Abbott Laboratories
Company Overview
Affymetrix
Company Overview
Agilent Technologies
Company Overview
Analytik Jena AG
Company Overview
Becton Dickinson & Co
Company Overview
BioFire Diagnostics, Inc
Company Overview
bioMerieux SA
Company Overview
Bio-Rad Laboratories, Inc
Company Overview
Cephid
Company Overview
Denville Scientific, Inc
Company Overview
Eppendorf AG
Company Overview
Exiqon A/S
Company Overview
Fluidigm Corporation
Company Overview
Illumina, Inc.
Company Overview
Kyratec
Company Overview
Life Technologies Corporation (part of Thermo Fisher)
Company Overview
Promega Corporation
Company Overview
Qiagen N.V.
Company Overview
RainDance Technology
Company Overview
Roche
Company Overview
Sacace Biotechnologies S. R. L.
Company Overview
Takaro Bio, Inc
Company Overview
Thermo Fisher Scientific
Company Overview
WaferGen Biosystems, Inc
Company Overview
APPENDIX: LIST OF COMPETITORS
LIST OF EXHIBITS
CHAPTER ONE: EXECUTIVE SUMMARY
Table 1-1
The qPCR Market 2011-2018
Figure 1-1
The qPCR Market 2011-2018
CHAPTER TWO: INTRODUCTION TO THE qPCR AND dPCR INDUSTRY
Table 2-1
PCR Technologies Comparison (Traditional, qPCR, Digital)
CHAPTER THREE: INDUSTRY TRENDS
Table 3-1
Total Healthcare Expenditures as a Percent of GDP by Country 1990, 2000 and 2011 (Australia, Austria, Canada, Czech Republic, Finland, France, Germany, Greece, Italy, Japan, Mexico, Switzerland, United Kingdom, United States)
Figure 3-1
Total Healthcare Expenditures as a Percent of GDP by Country 1990, 2000, and 2011 (United States, United Kingdom, Switzerland, Mexico, Japan,
Italy, Greece, Germany, France, Finland, Czech Republic, Canada, Austria, Australia)
Table 3-2
Estimated World Population by Age and Geographical Region, 2012
Figure 3-2
Estimated World Population by Age and Geographical Region, 2012
Table 3-3
Average Life Expectancy in Years by Country 1980 and 2012
Figure 3-3
Average Life Expectancy in Years by Country 1980 and 2012
Table 3-4
Selected Disease Statistics, Worldwide, as of July 2012
Figure 3-4
Elderly Support Ratio in Selected Countries (2050)
Table 3-5
BRIC and Emerging Nations Potential Market, mid-2014 (China, India, United States, Brazil, Russia, Mexico, Nigeria, Turkey, S. Korea, S. Africa, Vietnam, Poland)
Table 3-6
BRIC and Emerging Nations Healthcare Infrastructure Capacity (Russia, Poland, United States, Brazil, S. Korea, China, Mexico, Turkey, S. Africa, India, Vietnam, Nigeria)
CHAPTER FIVE: MARKET SIZE AND GROWTH
Table 5-1
The qPCR Market 2011-2018
Figure 5-1
The qPCR Market 2011-2018
Table 5-2
The Total qPCR and dPCR Market 2011-2018
Figure 5-2
The qPCR and dPCR Market Revenues 2011-2018
Table 5-3
The Total qPCR and dPCR Market by Product Type 2011-2018 (Reagents, Instruments, Software Services, Total, Percent Change)
Figure 5-3
The qPCR and dPCR Market Revenues 2011-2018
Figure 5-4
The qPCR Market Share by Use, 2013 (Clinical, Research, Other)
Figure 5-5
The dPCR Market Share by Use, 2013 (Clinical, Research, Other)
Table 5-4
The qPCR Market by Product Type 2011-2018 (Reagents, Instruments, Software & Services, Total, Percent Change)
Figure 5-6
The qPCR Market by Product Type 2011-2018 by Percent (Software/services, Instruments, Reagents)
Table 5-5
The dPCR Market by Product Type 2011-2018 (Reagents, Instruments, Software & Services, Total, Percent Change)
Figure 5-7
The Total Market by Product Type 2011-2018 by Percent (Software/services, Instruments, Reagents)
Figure 5-8
The Total qPCR Market Including the dPCR Market: Estimated Market Share by Geographic Region, 2013 (U.S., Europe, Japan, ROW)
